Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA advisory committee rejects Amphotec supplemental NDA

April 21, 1997

Zagam available in Germany

April 18, 1997

ImmuCell to initiate clinical trial of DiffGAM

April 18, 1997

Morinaga Milk claims new antiparasitic agents

April 18, 1997

Isis receives contract for combinatorial antibacterial drug research

April 16, 1997

Use of desbutylhalofantrine for malaria claimed

April 15, 1997

Tentative approval for Faulding's generic aciclovir for injection

April 14, 1997

University of Michigan researchers describe anti-HCMV agents

April 14, 1997

Encouraging results from preclinical trial of Atlantic's RSV therapy

April 11, 1997

Hybridon selects HPV drug candidate

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...